Dyssomnias in children Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languageDyssomnias in children MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:9 Jul 2023Last updated:08 Aug 2023SummaryDyssomnias (sleep disorders) in children include a range of diagnoses with varying aetiologies.Most
Dyssomnias in children Dyssomnias in children - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * About us * Help * Subscribe * Access through your institution * Log inBMJ Best Practice * Help * Getting started * FAQs * Contact us * Recent updates * Specialties * Calculators * Patient leaflets * Videos * Evidence * Drugs * Recent updates
Dyssomnias in children Dyssomnias in children - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * About us * Help * Subscribe * Access through your institution * Log inBMJ Best Practice * Help * Getting started * FAQs * Contact us * Recent updates * Specialties * Calculators * Patient leaflets * Videos * Evidence * Drugs * Recent updates
Impaired peri-olfactory cerebrospinal fluid clearance is associated with ageing, cognitive decline and dyssomnia. Animal experiments have demonstrated the dependency of cerebrospinal fluid clearance function on age and sleep, which partially underlay the cognitive decline in the elderly. However, human evidence is lacking, which could be mainly attributed to the limited methods of cerebrospinal
Longitudinal associations between parent, child, family factors and dyssomnias in children from birth to 8 years: The CIKEO study. Dyssomnias, are the most common parent-reported sleep complaints in young children. The present study investigated the prevalence, one-year development (incidence and persistence) of dyssomnia in early childhood, and the parent, child, and family factors associated with dyssomnia. Longitudinal data of 700 children aged 0-8, gathered in the CIKEO cohort study in the Netherlands were analyzed. Dyssomnias were defined as the presence of night awakenings ≥3 times per night or sleep-onset latency of >30 min. Least absolute shrinkage and selection operator (LASSO) was used to identify the parental, child, and family factors associated with the incidence and persistence
Mean Blood Pressure Difference among Adolescents Based on Dyssomnia Types Dyssomnia is the most frequent sleep disturbance and associated with increased blood pressure. There has been no study determining the difference in mean blood pressure based on dyssomnia types among adolescents. To determine the difference in mean blood pressure among adolescents based on dyssomnia types. Cross-sectional significant. Seventy-six samples were obtained with mean age 13.9 (SD 1.14) years - old. Dyssomnia proportion and hypertension were 72/76 and 20/76 respectively. Mean systolic (SBP) and diastolic blood pressure (DBP) was 111.1 (SD 16.46) mmHg and 70.3 (SD 11.98) mmHg respectively. Mean SDSC score was 49.7 (SD 8.96), and the most frequent dyssomnia type was disorders of initiating and maintaining sleep. Age
Morning surge in blood pressure and sympathetic activity in Mongolians and Han Chinese: a multimodality investigation of hypertension and dyssomnia Hypertension and dyssomnia are increasing significantly in Mongolians, and the related factors of ethnic differences in hypertension and dyssomnia between Mongolians and Han Chinese are unclear. This study examined the relationship of morning surge in blood pressure (MBP) with ethnicity, sleep situation, and sympathetic activity throughout the day. Of 692 hypertensive patients screened, 202 subjects with dyssomnia were selected. They were then divided into Mongolian ( = 87) and Han ( = 115) groups. The differences in dyssomnia, 24-h blood pressure, and urinary catecholamine were analyzed in all subjects; they were then further divided according
RAI1 Overexpression Promotes Altered Circadian Gene Expression and Dyssomnia in Potocki–Lupski Syndrome ( ) encodes a dosage-sensitive gene that when haploinsufficient results in Smith-Magenis syndrome (SMS) and when overexpressed results in Potocki-Lupski syndrome (PTLS). Phenotypic and molecular evidence illustrates that haploinsufficiency of disrupts circadian rhythm through % of individuals manifested moderate to severe sleep latency, as defined by the PSQI. Moreover, these individuals manifested difficulties in sleep maintenance, with middle of the night and early morning awakenings. When assessing daytime sleepiness through the Epworth Sleepiness Scale, approximately 21% of the individuals manifested excessive daytime somnolence. This indicates that mild dyssomnia characterizes
Association between exposure to air pollution and risk of Dyssomnia: A systematic review and meta-analysis PROSPEROInternational prospective register of systematic reviews Print | PDFAssociation between exposure to air pollution and risk of Dyssomnia: A systematic review and meta-analysisqiuzhi CAO, Li SunTo enable PROSPERO to focus on COVID-19 submissions, this registration record has of Dyssomnia: A systematic review and meta-analysis. PROSPERO 2024 CRD42024501907 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024501907Review questionIs exposure to air pollution associated with the risk of Dyssomnia?SearchesPubMed/Web of Science/Embase/EnglishTypes of study to be includedcross-sectional, case-control or cohort studiesCondition or domain being
37 Search terms Items found Population: 1. ‘sleep disorder’/exp 256 001 2. (sleep* OR dyssomnia 64 Search terms Items found Population: 1. TITLE-ABS-KEY(sleep* OR dyssomnia OR parasomnia OR somnolence OR insomnia OR hypersomn*) 360 151 Intervention
, dyssomnia, and hot flushes. SUVN-G3031 exposure was dose proportional across the tested doses. Steady state was achieved on day 6 after once-daily dosing. Renal excretion (~ 60%) of unchanged SUVN-G3031 was the major route of elimination. Food, gender, and age did not have any clinically meaningful effect on SUVN-G3031 exposure. SUVN-G3031 was found to be safe and well tolerated in healthy human subjects